期刊文献+

光动力治疗宫颈高危型人乳头状瘤病毒感染性疾病的疗效及护理 被引量:3

The 5-aminolevulinic acid photodynamic therapy in the treatment of high-risk human papillomavirus infection and related nursing management
下载PDF
导出
摘要 目的观察外用盐酸氨酮戊酸散光动力疗法(ALA-PDT)在治疗高危型人乳头状瘤病毒(HPV)持续性感染中的有效性,总结护理措施。方法选取高危型HPV感染时间>12个月的25例患者,根据宫颈解剖结构特点选择宫颈上药方式,并在治疗的不同阶段实施护理干预。治疗后4周观察HPV的转阴率及不良反应。结果25例患者均完成治疗,累积阴转率为84.00%(21/25)。结论ALA-PDT是一种安全、有效的高危型HPV持续性感染的治疗方法。在治疗过程中应开展综合护理措施和人文关怀,改善患者负性情绪。 Objective To observe the effect of 5-aminolevulinic acid photodynamic therapy(ALA-PDT)in the treatment of high-risk human papillomavirus(HR-HPV)infection,and summarize related nursing interventions during the treatment.Methods Totally 25 patients with HR-HPV positive for more than 12 months were included in this study.The 5-aminolevulinic acid was used according to the anatomical features of cervix uteri.The comprehensive nursing was carried out during the period of ALA-PDT.The rate of negative conversion of HPV and adverse reaction were observed at 4 weeks after treatment.Results All 25 patients completed the trail of ALA-PDT.The cumulative negative conversion rate was 84.00%(21/25).Conclusion The ALA-PDT is a safe and effective treatment for HR-HPV infection.It is also required to carry out comprehensive nursing interventions and humanistic care during the treatment,in order to relieve the negative emotion of patients.
作者 林琳 LIN Lin(Outpatient Department of Gynecology,The Third Affiliated Hospital of Soochow University,Changzhou,Jiangsu,213004)
出处 《中西医结合护理(中英文)》 2019年第7期94-96,共3页 Journal of Clinical Nursing in Practice
基金 常州市卫生计生委重大科技项目(ZD201807)
关键词 光动力疗法 人乳头状瘤病毒 宫颈疾病 病毒感染 盐酸氨酮戊酸 photodynamic therapy human papillomavirus cervical disease virus infection 5-aminolevulinic acid
  • 相关文献

参考文献6

二级参考文献68

  • 1王宏伟,王秀丽,过明霞,虞叶风.5-氨基酮戊酸乳膏光动力疗法治疗皮肤癌前病变和皮肤原位癌[J].中华皮肤科杂志,2006,39(3):137-139. 被引量:49
  • 2李霓,马聪萍,孙立新,张永贞,张永贞,邢菊霞,邵淑丽,邢菊霞,鲍彦平,黄瑞德,贺立绩,乔友林.碘染色肉眼观察作为宫颈癌初筛方法的效果评价[J].中华流行病学杂志,2006,27(1):15-18. 被引量:38
  • 3涂平,郑和义,顾恒,徐金华,王秀丽,陈伟,李军,陈昆,陆小年,王宏伟,朱学骏.外用盐酸氨基酮戊酸光动力疗法治疗尖锐湿疣多中心随机对照研究[J].中华皮肤科杂志,2007,40(2):67-70. 被引量:122
  • 4Dalstein V ,Rielhmuller D,Prtet JL,et al. Persistent and load of high-risk HPV are predictors for development of high-grade cervical lesions : a longitudinal French cohort study[J], Int J Cancer,2003,106(3) :396-403.
  • 5Oh ST,Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction human telomerase reverse transcriptase expression through Myc and GC-rich SPI binding sites[J]. J Virol,2001,75(12) :55-59.
  • 6Ferenczy A, Fravco E. Persistent human papillomavirus infection and cervical neoplasia [ J ]. Lancet Oncol,2002,3 ( 1 ) : 11-16.
  • 7Albrechtsen S, Rasmussen S, Thoresen S, et al. Pregnancy outcome in women before and after cervical conisation: population based cohort study[J]. BMJ ,2008, 337 : 1350.
  • 8Crane J, Delaney T, Hutchens D. Transvaginal ultrasonog-raphy in the prediction of preterm birth after treatment for cervical intraepithelial neoplasia [ J ]. Obstet Gynecol,2006,107 ( 1 ) :37-44.
  • 9Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: Systematic review and meta-analysis [ J ]. Lancet, 2006, 367 ( 9509 ) :489-498.
  • 10Hillemanns P, Wang X, Hertel H, et al. Pharmacokineties and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia[ J ]. Am J Obstet Gynecol,2008 198 (3) :1-7.

共引文献155

同被引文献17

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部